MedTrace Logo

Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

NCT05915871 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-06-23

No results posted yet for this study

Summary

To evaluate the pharmacokinetic interaction between tegoprazan and combination of Amoxicillin, Clarithromycin and bismuth in healthy adult volunteers.

Conditions

  • Healthy

Interventions

DRUG

Tegoprazan

Tablet for oral administration

DRUG

Bismuth

Capsule for oral administration

DRUG

Amoxicilli

Capsule for oral administration

DRUG

Clarithromycin

Tablet for oral administration

Sponsors & Collaborators

  • Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2023-04-28
Completion
2023-04-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05915871 on ClinicalTrials.gov